[1]
“Evaluation of risk factors in patients with breast cancer in stages III and IV: comparison of Cox and Fine-Grey competing risk regression models”, Biomed. Res. Ther., vol. 5, no. 02, pp. 2022–2033, Feb. 2018, doi: 10.15419/bmrat.v5i02.417.